US Antibody Drug Conjugates (ADC) Market: Precision Oncology, Biotech Innovation, and Targeted
The US Antibody Drug Conjugates (ADC) Market is at the forefront of oncology innovation, offering highly targeted treatment options that combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs. ADCs are designed to deliver chemotherapy directly to … Read more